Kaposi's sarcoma complicating long-term corticotherapy for rheumatoid arthritis
Kaposi's sarcoma (KS) is a lymphoangioproliferative neoplasm induced by human herpes virus 8 (HHV-8). KS caused by iatrogenic immunosuppression is rare. Iatrogenic KS can present a therapeutic dilemma, as decreasing the level of immunosuppression may not be possible or may come at the high cost...
Saved in:
Main Authors: | Sara Elloudi (Author), Hakima Elmahi (Author), Salim Gallouj (Author), Fatima Zahra Mernissi (Author) |
---|---|
Format: | Book |
Published: |
Our Dermatology Online,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relationship between corticotherapy and increased cardiac risk in patients with rheumatoid arthritis
by: Elisangela Gueiber Montes, et al.
Published: (2021) -
Kaposi sarcoma in a patient treated with upadacitinib for rheumatoid arthritis
by: Cynthia Fournier, MD, FRCPC, et al.
Published: (2023) -
Case for diagnosis: A particular form of a common disease
by: Sara Elloudi, et al.
Published: (2017) -
Sarcoma de Kaposi. Una revisión Kaposi's sarcoma
by: Lilia María de la Torre Navarro, et al.
Published: (2010) -
Long-Term Response of Classic Kaposi's Sarcoma to Intralesional Doxorubicin: A Case Report
by: Yasir Azim Mirza, et al.
Published: (2015)